Comparison of hemodialysis and peritoneal dialysis -: A cost-utility analysis

被引:7
作者
Sennfält, K [1 ]
Magnusson, M
Carlsson, P
机构
[1] Linkoping Univ, Ctr Med Technol Assessment, S-58381 Linkoping, Sweden
[2] Linkoping Univ Hosp, Dept Nephrol, S-58185 Linkoping, Sweden
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2002年 / 22卷 / 01期
关键词
cost-utility analysis; decision tree; hemodialysis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
. Objective: Our aim was to compare both health-related quality of life and costs for hemodialysis (HD) and peritoneal dialysis (PD) in a defined population. . Design: Decision-tree modeling to estimate total costs and effects for two treatment strategies, HD and PD, among patients with chronic kidney failure, for 5 years following the start of treatment. Courses of events and health-care consumption were mapped in a retrospective matched-record study. Data on health status were obtained from a matched population by a quality-of-life questionnaire (EuroQol). The study has a societal perspective. . Setting: All dialysis departments in the southeastern health-care region of Sweden. . Patients: 136 patients with kidney failure, comprising 68 matched pairs, were included in a retrospective record study; 81 patients with kidney failure, comprising 27 matched triplets, were included in a prospective questionnaire study. . Main Outcome Measures: Cost per life year and cost per quality-adjusted life year. . Results: The cost per quality-adjusted life year for PD was lower in all analyzed age groups. There was a 12% difference in the age group 21 - 40 years, a 31% difference in the age group 41 - 60 years, and an 11% difference in the age group 61+ years. Peritoneal dialysis and HD resulted in similar frequencies of transplantation (50% and 41%, respectively) and expected survival (3.58 years and 3.56 years, respectively) during the first 5 years after the initiation of treatment. . Conclusion:The cost-utility ratio is most favorable for PD as the primary method of treatment for patients eligible for both PD and HD.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 25 条
[1]  
[Anonymous], 1995, MEASUREMENT VALUATIO
[2]   A COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS AND HOSPITAL HEMODIALYSIS [J].
CHURCHILL, DN ;
LEMON, BC ;
TORRANCE, GW .
MEDICAL DECISION MAKING, 1984, 4 (04) :489-500
[3]  
CROXSON BE, 1990, NEW ZEAL MED J, V103, P171
[4]  
*EUR GROUP, 1996, EQ 5D US GUID MEAS H
[5]  
Garella S, 1997, NEPHROL DIAL TRANSPL, V12, P10
[6]  
Goeree R, 1995, CLIN INVEST MED, V18, P455
[7]  
Gold MR, 1996, COST EFFECTIVENESS H
[8]   COMPARISON BETWEEN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS AND IN CENTER HEMODIALYSIS [J].
HURAIB, S ;
ABUAISHA, H ;
MITWALLI, A ;
MEMON, NA ;
SULIMANI, F ;
AGRAHARKAR, M .
ANNALS OF SAUDI MEDICINE, 1990, 10 (04) :394-398
[9]  
Jacobs C, 1997, NEPHROL DIAL TRANSPL, V12, P29
[10]   COST-EFFECTIVENESS STUDIES OF RENAL-TRANSPLANTATION [J].
KARLBERG, I ;
NYBERG, G .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1995, 11 (03) :611-622